These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 9435926

  • 1. Pharmaceutical aspects of docetaxel.
    Kraynak MA.
    Am J Health Syst Pharm; 1997 Dec 15; 54(24 Suppl 2):S7-10. PubMed ID: 9435926
    [Abstract] [Full Text] [Related]

  • 2. Docetaxel: a taxoid for the treatment of metastatic breast cancer.
    Tankanow RM.
    Am J Health Syst Pharm; 1998 Sep 01; 55(17):1777-91. PubMed ID: 9775340
    [Abstract] [Full Text] [Related]

  • 3. The role of taxanes in the treatment of breast cancer.
    Capri G, Tarenzi E, Fulfaro F, Gianni L.
    Semin Oncol; 1996 Feb 01; 23(1 Suppl 2):68-75. PubMed ID: 8614849
    [Abstract] [Full Text] [Related]

  • 4. Risks and benefits of taxanes in breast and ovarian cancer.
    Michaud LB, Valero V, Hortobagyi G.
    Drug Saf; 2000 Nov 01; 23(5):401-28. PubMed ID: 11085347
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials.
    Sparano JA.
    Clin Breast Cancer; 2000 Apr 01; 1(1):32-40; discussion 41-2. PubMed ID: 11899388
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Weekly administration of docetaxel (Taxotere): summary of clinical data.
    Hainsworth JD, Burris HA, Greco FA.
    Semin Oncol; 1999 Jun 01; 26(3 Suppl 10):19-24. PubMed ID: 10437747
    [Abstract] [Full Text] [Related]

  • 12. Docetaxel as single-agent therapy in metastatic breast cancer: clinical efficacy.
    Valero V.
    Semin Oncol; 1997 Aug 01; 24(4 Suppl 13):S13-11-S13-18. PubMed ID: 9335512
    [Abstract] [Full Text] [Related]

  • 13. Docetaxel in patients with anthracycline-resistant advanced breast cancer.
    Vici P, Belli F, Di Lauro L, Amodio A, Conti F, Foggi P, Gionfra T, Morelli MF, Botti C, Ferraironi A, Lopez M.
    Oncology; 2001 Aug 01; 60(1):60-5. PubMed ID: 11150910
    [Abstract] [Full Text] [Related]

  • 14. [Docetaxel].
    Suzuki Y, Tokuda Y.
    Gan To Kagaku Ryoho; 2001 Oct 01; 28(10):1363-7. PubMed ID: 11681243
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Docetaxel.
    Cortes JE, Pazdur R.
    J Clin Oncol; 1995 Oct 01; 13(10):2643-55. PubMed ID: 7595719
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis.
    Tomiak E, Piccart MJ, Kerger J, Lips S, Awada A, de Valeriola D, Ravoet C, Lossignol D, Sculier JP, Auzannet V.
    J Clin Oncol; 1994 Jul 01; 12(7):1458-67. PubMed ID: 7912725
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.